Smoking, alcohol consumption, and the risk of extrahepatic cholangiocarcinoma: a meta-analysis
- PMID: 24379600
- PMCID: PMC3870528
- DOI: 10.3748/wjg.v19.i46.8780
Smoking, alcohol consumption, and the risk of extrahepatic cholangiocarcinoma: a meta-analysis
Abstract
Aim: To assess the association between smoking and alcohol consumption and extrahepatic cholangiocarcinoma (ECC) through a meta-analysis of clinical observational studies.
Methods: A literature search was conducted using Embase and MEDLINE databases from inception to 31 May 2013 without language limitations, and by manually searching the references of retrieved articles. Case-control and cohort studies that investigated the association between smoking or alcohol consumption and ECC were included. The quality of these studies was assessed using the Newcastle-Ottawa quality assessment scale. Summary relative risks and corresponding 95%CI were calculated using a random-effects model. Publication bias was assessed by Begg's funnel plot and Egger's test.
Results: A total of 12 eligible articles (11 case-control studies and one cohort study) were included in this meta-analysis. Eleven studies reported the association between smoking and ECC. Pooled analysis indicated that smokers had an increased risk of ECC development as compared with non-smokers (summary RR = 1.23; 95%CI: 1.01-1.50). This correlation was present in population-based studies (n = 5; summary RR = 1.47; 95%CI: 1.06-2.05) but not in hospital-based studies (n = 6; summary RR = 1.10; 95%CI: 0.88-1.37) and in non-Asian regions (n = 7; summary RR = 1.39; 95%CI: 1.03-1.87) but not in Asia (n = 4; summary RR = 1.08; 95%CI: 0.85-1.38). Seven studies reported an association between consuming alcohol and ECC. Pooled analysis indicated that alcohol drinkers had a similar risk of ECC development as did individuals who did not drink alcohol (summary RR = 1.09; 95%CI: 0.87-1.37). There was moderate heterogeneity among the studies and no evidence of publication bias.
Conclusion: Smoking is associated with an increased risk of ECC, but alcohol consumption is not. Further population-based studies, particularly cohort studies, are warranted to enable definitive conclusions.
Keywords: Alcohol consumption; Extrahepatic cholangiocarcinoma; Meta-analysis; Relative risk; Smoking.
Figures





Similar articles
-
Diabetes mellitus and increased risk of extrahepatic cholangiocarcinoma: a meta-analysis.Hepatogastroenterology. 2013 Jun;60(124):684-7. doi: 10.5754/hge12966. Hepatogastroenterology. 2013. PMID: 23321031
-
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.J Hepatol. 2020 Jan;72(1):95-103. doi: 10.1016/j.jhep.2019.09.007. Epub 2019 Sep 16. J Hepatol. 2020. PMID: 31536748
-
Smoking, Alcohol, and Biliary Tract Cancer Risk: A Pooling Project of 26 Prospective Studies.J Natl Cancer Inst. 2019 Dec 1;111(12):1263-1278. doi: 10.1093/jnci/djz103. J Natl Cancer Inst. 2019. PMID: 31127946 Free PMC article. Review.
-
Diabetes mellitus and increased risk of cholangiocarcinoma: a meta-analysis.Eur J Cancer Prev. 2012 Jan;21(1):24-31. doi: 10.1097/CEJ.0b013e3283481d89. Eur J Cancer Prev. 2012. PMID: 21857525
-
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study.Am J Gastroenterol. 2007 May;102(5):1016-21. doi: 10.1111/j.1572-0241.2007.01104.x. Epub 2007 Feb 23. Am J Gastroenterol. 2007. PMID: 17324130
Cited by
-
The diagnosis and treatment of cholangiocarcinoma.Dtsch Arztebl Int. 2014 Oct 31;111(44):748-54. doi: 10.3238/arztebl.2014.0748. Dtsch Arztebl Int. 2014. PMID: 25412632 Free PMC article. Review.
-
The causal relationship between metabolic factors, drinking, smoking and intrahepatic cholangiocarcinoma: a Mendelian randomization study.Front Oncol. 2023 Jun 22;13:1203685. doi: 10.3389/fonc.2023.1203685. eCollection 2023. Front Oncol. 2023. PMID: 37427123 Free PMC article.
-
Associations between cigarette smoking and biliary tract cancer by anatomic subsite and sex: a prospective cohort study in Japan.Cancer Causes Control. 2022 Nov;33(11):1335-1341. doi: 10.1007/s10552-022-01600-y. Epub 2022 Aug 27. Cancer Causes Control. 2022. PMID: 36030296 Free PMC article.
-
Investigating VEGF. miR-145-3p, and miR-101-3p Expression in Patients with Cholangiocarcinoma.Asian Pac J Cancer Prev. 2022 Jul 1;23(7):2233-2241. doi: 10.31557/APJCP.2022.23.7.2233. Asian Pac J Cancer Prev. 2022. PMID: 35901327 Free PMC article.
-
Association between Smoking Cessation and the Risk of Cholangiocarcinoma and Ampulla of Vater Cancer: A Nationwide Cohort Study.Liver Cancer. 2023 Feb 9;12(5):457-466. doi: 10.1159/000529609. eCollection 2023 Oct. Liver Cancer. 2023. PMID: 37901767 Free PMC article.
References
-
- Welzel TM, McGlynn KA, Hsing AW, O’Brien TR, Pfeiffer RM. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst. 2006;98:873–875. - PubMed
-
- Khan SA, Emadossadaty S, Ladep NG, Thomas HC, Elliott P, Taylor-Robinson SD, Toledano MB. Rising trends in cholangiocarcinoma: is the ICD classification system misleading us? J Hepatol. 2012;56:848–854. - PubMed
-
- Shaib YH, Davila JA, McGlynn K, El-Serag HB. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol. 2004;40:472–477. - PubMed
-
- Wood R, Brewster DH, Fraser LA, Brown H, Hayes PC, Garden OJ. Do increases in mortality from intrahepatic cholangiocarcinoma reflect a genuine increase in risk? Insights from cancer registry data in Scotland. Eur J Cancer. 2003;39:2087–2092. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical